Method Article
The soft agar colony formation assay is a method used to confirm cellular anchorage-independent growth in vitro. The goal of this protocol is to illustrate a stringent method for the detection of the tumorigenic potential of transformed cells and the tumor suppressive effects of proteins on transformed cells.
Anchorage-independent growth is the ability of transformed cells to grow independently of a solid surface, and is a hallmark of carcinogenesis. The soft agar colony formation assay is a well-established method for characterizing this capability in vitro and is considered to be one of the most stringent tests for malignant transformation in cells. This assay also allows for semi-quantitative evaluation of this capability in response to various treatment conditions. Here, we will demonstrate the soft agar colony formation assay using a murine lung carcinoma cell line, CMT167, to demonstrate the tumor suppressive effects of two members of the Wnt signaling pathway, Wnt7A and Frizzled-9 (Fzd-9). Concurrent overexpression of Wnt7a and Fzd-9 caused an inhibition of colony formation in CMT167 cells. This shows that expression of Wnt7a ligand and its Frizzled-9 receptor is sufficient to suppress tumor growth in a murine lung carcinoma model.
The soft agar colony formation assay is a technique widely used to evaluate cellular transformation in vitro. Historically, another assay, the clonogenic assay, described by Puck et al. in 1956 was used to evaluate the ability of cells to form colonies1. In this technique, cells were dispersed onto a culture plate and grown in the presence of 'feeder' cells or conditioned medium to provide necessary growth factors. The limitation of this technique was that it only provided information regarding colony formation. Normal cells are prevented from anchorage-independent growth, due to a particular type of apoptotic death, called anoikis2. However, transformed cells have the capability to grow and divide without binding to a substrate. To capitalize on this concept, researchers developed the soft agar colony formation assay. The soft agar colony formation assay has since been modified, in more recent years, to address specific needs. One variation involves incorporation of fluorometric dye to allow for high-throughput colony counting. Another variation involves the use of specialized agar solution to allow for retrieval of viable cells after colony formation when protein or DNA samples are needed.
In the traditional soft agar colony formation assay, cells are grown in a layer of soft agar mixed with cell culture medium that rests on another layer of soft agar, also mixed with cell culture medium, but containing a higher concentration of agar. This prevents cells from adhering to the culture plate, yet allows transformed cells to form visible colonies. The rationale behind this technique is that normal cells depend on cell to extracellular matrix contact to be able to grow and divide. Conversely, transformed cells have the ability to grow and divide irrespective of their surrounding environment. Therefore, cells able to form colonies in an anchorage-independent manner were considered to be transformed and carcinogenic. The overall goal of this method is to measure this capability in cells in a semi-quantitative and stringent manner.
The Wnt signaling pathway is critical in embryogenesis and often de-regulated in tumorigenesis3-6. There are multiple pathways associated with Wnt signaling. The canonical pathway involves Wnt signaling and regulation of downstream gene transcription through its effects on the transcriptional coactivator beta-catenin. Wnts also signal through several non-canonical pathways, for example, the planar cell polarity pathway, which regulates elements involved in cytoskeletal structure7, and the Wnt-calcium pathway, which regulates release of calcium from the endoplasmic reticulum8. Wnt ligands exert their activity through binding Frizzled receptors. Although several Wnts have been shown to be upregulated in lung cancer, Wnt7a has been shown to be down-regulated in non-small cell lung cancer through promoter methylation9. Wnt7a binds Fzd9 and acts as a tumor suppressor through a non-canonical pathway. Restoration of Wnt-7a and Fzd-9 inhibits the growth of non-small cell lung cancer cells10. The effects of Wnt7a/Fzd9 are mediated through the activation of ERK-5, which in turn, activates peroxisome proliferator-activated receptor γ (PPARγ)11,12. Here, we show that overexpression of Wnt7a and Fzd9 results in the suppression of anchorage-independent growth of a murine lung carcinoma cell line. Murine CMT167 cells were derived from a lung carcinoma in C57BL/lcrf mice13 and were stably transfected with Wnt7A and Fzd9. Overexpression of Wnt7A and Fzd9 were confirmed by quantitative-PCR (Q-PCR) and the functionality of Wnt7A and Fzd9 overexpression was confirmed through downstream activation of PPARγ.
1. Preparation of Materials and Reagents
2. Plating of Bottom Layer of Agar
3. Plating the Upper Layer of Agar Containing Cells
4. Staining the Plates and Counting Colonies
The expression of Wnt7A and Fzd9 in CMT167 cells is effective in tumor suppression as illustrated by our soft agar colony formation assay. Preliminarily, we used Q-PCR to show that Wnt7A and Fzd9 mRNA are expressed in low levels in CMT167 cells. CMT167 cells showed low levels of endogenous Wnt7A and Fzd9 when compared to MLE-12 cells, an SV40-transformed murine lung epithelial cell line (Figure 1). We then transfected CMT167 cells with two retroviral overexpression vectors expressing human constructs of Wnt7A (LNCX-Wnt7A) and Fzd9 (LPCX-Fzd9) to create a stable cell line that expresses both Wnt7A and Fzd9 (CMT LL Wnt7a/Fzd9). We confirmed expression of Wnt7A and Fzd9 by Q-PCR in this cell line (Figure 2). As our previous work has shown, PPARγ is a downstream effector of Wnt7A/Fzd9 signaling. Wnt signaling pathways are diverse. Therefore, proper expression and activation of a particular Wnt and its Fzd receptor must be assessed using a downstream effector that is known to be activated by the Wnt/Fzd pair of interest. For Wnt7A and Fzd9, PPARγ was chosen for this reason. We transfected CMT167 cells overexpressing empty vectors (LNCX/LPCX) or Wnt7A/Fzd9 with a Luciferase reporter construct containing a PPARγ response element. We showed that our CMT167 LL Wnt7A/Fzd9 cell line had almost six-fold increased PPAR-RE activity (Figure 3). Finally, as mentioned previously, to confirm the tumor suppressor activity of Wnt7A and Fzd9 in vitro, we performed a soft agar colony formation assay. CMT167 vector expressing and Wnt7A/Fzd9 expressing stable cell lines were plated onto soft agar plates and allowed to form colonies for two to three weeks. CMT167 LL Wnt7A/Fzd9 cells formed significantly less colonies when compared to vector-transfected cells, illustrating the tumor suppressor function of Wnt7A and Fzd9 (Figure 4). Pictures were taken of all plates, and colonies were counted using an imager and imaging software.
Figure 1: Decreased levels of Wnt7A and Fzd9 mRNA in CMT167 cells compared to MLE-12 cells. Q-PCR analysis was performed to determine mRNA levels of Wnt7a and Fzd9 normalized to GAPDH. Levels in CME167 murine lung carcinoma cells were compared to those in MLE-12 SV40-transformed murine lung epithelial cells, which were normalized to 1.0. CMT167 cells showed lower levels of Wnt7a (A) and Fzd9 (B) mRNA when compared to MLE-12 cells.
Figure 2: Overexpression of Wnt7a/Fzd9 in CMT167 LL Wnt7a/Fzd9 stable cell line. Wnt7A/Fzd9 stable overexpression human constructs were made using an LNCX retroviral vector. Q-PCR was performed for Wnt7A and Fzd9, and mRNA levels were normalized to GAPDH in empty-vector transfected cells and in Wnt7A/Fzd9 overexpressing cells. CMT167 LL Wnt7a/Fzd9 cells expressed high levels of Wnt7a (A) and Fzd9 (B) mRNA.
Figure 3: CMT167 Wnt7a/Fzd9 stable overexpressing cell line exhibits increased PPAR-RE promoter activity. CMT167 LL Wnt7a/Fzd9 or empty vector CMT167 LNCX/LPCX stable overexpressing cells were transfected with a PPAR response element promoter luciferase plasmid using Lipofectamine reagent. Promoter activity was quantified compared to vector-transfected cells, where promoter activity was normalized to 1.0. CMT167 LL Wnt7a/Fzd9 stable overexpressing cells showed an approximately six-fold increase in PPAR promoter activity.
Figure 4: Soft Agar Colony Formation Assay of vector-expressing CMT167 LNCX/LPCX cells and CMT167 LL Wnt7a/Fzd9 overexpressing cells. Vector-expressing CMT167 LNCX/LPCX cells and CMT167 LL Wnt7A/Fzd9 overexpressing cells were plated in a soft agar colony formation assay per protocol described above. CMT167 LL Wnt7A/Fzd9 cells showed a marked decrease in colony formation. Representative wells showing colonies for each cell line. Picture of wells are representative of three independent experiments.
In vitro confirmation of tumor suppressive function of signaling proteins is difficult. One of the most rigorous assays available to investigate this property is the soft agar colony formation assay. Here, we have illustrated the soft agar colony formation assay using a murine lung carcinoma cell line stably overexpressing Wnt7a and Fzd9 compared to its parental CMT167 cell line.
There are several important points to consider regarding the soft agar assay. The most critical step in this assay is plating of the cells. Cell counts must be accurate, and the agar solution must not be too hot. If no colonies are formed, the cells may have been damaged due to heat stress. In this situation, the assay should be repeated, taking precautions to keep agar temperature as close to 42 °C as possible. Alternatively, a greater number of cells can be plated.
There are a few limitations to the soft agar assay. One such limitation is that it takes two to three weeks for completion. Another is that it does not allow for cell retrieval upon completion. Modifications of this technique employ specialized agar solutions to allow for cells to be harvested for DNA or protein upon assay completion. Alternative methods also utilize fluorometric dye to allow for high throughput assays. Nevertheless, the traditional soft agar colony formation assay remains as one of the most rigorous tests for confirmation of anchorage-independent cell growth.
The authors have nothing to disclose.
This study was supported by a Merit Award from the U.S. Department of Veterans Affairs, and an NIH grant R01CA1385282522717 to RW.
Name | Company | Catalog Number | Comments |
Cancer Cell Line of Interest | Sigma-Aldrich | 10032302 | CMT-167 Cells |
Powdered RPMI 1640 Medium | Gibco | 31800-089 | Used to prepare 2x cell culture medium. |
Liquid RPMI 1650 Medium | Cellgro | 10-040-CV | Referred to as 1x cell culture medium. |
Fetal Bovine Serum | HyClone | SH30910.03 | Used to supplement cell culture medium. |
Penicillin/Streptomycin | CellGro | 30-002-Cl | Used in cell culture medium. |
Difco Noble Agar | BD Biosciences | 214230 | Used to prepare 1.0% and 0.6% agar. |
Sodium Bicarbonate | Fisher | BP-328-1 | Used in 2x cell culture medium. |
Trypsin | Cellgro | 25-050-Cl | |
Sterile Bottle-Top Filters | Fisher | 09-761-126 | Used to sterile filter 2x medium. |
Lipofectamine Reagent | Invitrogen | 18324-020 | Used in PPAR-RE luciferase assay. |
6-well Plates Tissue-culture Treated | |||
37 °C/5% CO2 Incubator | |||
Chemi-Doc Imager | Bio-Rad | Used to take pictures of colonies. | |
Quantity One Software | Bio-Rad | Used to count cell colonies. | |
15 ml Conical Tubes | |||
50 ml Conical Tubes | |||
250 ml Erlenmeyer Flasks | |||
Microwave | |||
5 ml Serological Pipettes | |||
Pipette Aid | |||
Micropipette | |||
Hemacytometer w/ cover slip | |||
Pipette Tips | |||
Inverted Light Microscope | |||
Centrifuge | |||
Heat-Resistant Gloves | |||
Saran Wrap | |||
Ice Bucket |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved